DERMATOLOGICALS IN JAPAN

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Dermatologicals Continues To Grow Due To Rising Awareness of Symptoms

New Product Launches

Internet Retailing Continues To Rise

Competitive Landscape

the Competition Heats Up in Hair Loss Treatments

Self-medication Is Chosen Over Prescription Medication

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Executive Summary

the Healthy Living Mindset Spreads, Leading To Growth in Sports Nutrition

Disappointing Impact of the New Tax System on OTC Products

Players Offering Switched OTC Products Enjoy Growth

Internet Retailing Rises, Whilst Drugstores/parapharmacies Continues To Lead

Continued Growth Is Expected, As Consumers' Health Concerns Rise

Market Indicators

Table 5 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 6 Life Expectancy at Birth 2013-2018

Market Data

Table 7 Sales of Consumer Health by Category: Value 2013-2018

Table 8 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 9 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 10 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 11 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 12 Distribution of Consumer Health by Format: % Value 2013-2018

Table 13 Distribution of Consumer Health by Format and Category: % Value 2018

Table 14 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 15 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

Dermatologicals showed moderate current value growth in 2018. Vaginal antifungals and cold sore treatments showed stronger growth than other categories, as they had not yet fully matured and there was a great deal of room for growth. For instance, OTC cold sore treatments have only been available in the country since 2007. The symptoms of cold sores are also increasingly understood, with more consumers therefore looking for treatment. Such products typically indicate and are promoted that they c...

Euromonitor International's Dermatologicals in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.